Adreno Pharmaceuticals Private Limited
About Adreno Pharmaceuticals Private Limited
Data last updated:
Adreno Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 08 September 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U33100DL2016PTC305661. Its GSTIN is 07AAOCA7338Q1ZU (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Adreno Pharmacuticals Private Limited. It is led by directors Prasenjit Nandi and Kabita Roy.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unit No. G – 11 Ground Floor Vardhman Ac Market C.S.C Block – E Sector – 18 Rohini New De, Lhi, New Delhi, Delhi, India – 110089.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.54 Lakh, a decline of 24% compared to the previous year. For the same year it recorded a net loss of ₹1.02 Lakh (net margin -13.6%) and EBITDA of ₹65,180 (EBITDA margin 8.6%). Revenue has grown at a compounded annual rate (CAGR) of 24% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹6.43 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Adreno Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnit No. G – 11 Ground Floor Vardhman Ac Market C.S.C Block – E Sector – 18 Rohini New De, Lhi, New Delhi, Delhi, India – 110089
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Adreno Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Adreno Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Adreno Pharmaceuticals Private Limited, buy the company report.
Financials of Adreno Pharmaceuticals Private Limited
FY 2025 filings availableAdreno Pharmaceuticals Private Limited reported revenue of ₹7.54 Lakh (down 24% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 24% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 4%. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹65,180 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 8.6% | ||||
| Net Profit Margin | -13.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Adreno Pharmaceuticals Private Limited, buy the company report.
Board of directors of Adreno Pharmaceuticals Private Limited
Adreno Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prasenjit Nandi | Director | 08 Sep 2016 | 10 Years 1 Months | Current |
| Kabita Roy | Director | 04 Jun 2019 | 7 Years 4 Months | Current |
Peer comparison
Adreno Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medopex Remedies Private Limited | ₹7.56 Lakh (FY 2025) | 72.0% | Yavatmal, Maharashtra, India | |||
| Adreno Pharmaceuticals Private Limitedthis company | ₹7.54 Lakh (FY 2025) | -₹1.02 Lakh | -13.6% | -24.0% | New Delhi, Delhi, India | |
| Ulabs Private Limited | ₹7.54 Lakh (FY 2024) | -94.0% | Manimajra, Chandigarh, India | |||
| Sangfroid Medi Care Private Limited | ₹7.54 Lakh (FY 2019) | -77.0% | Gwalior, Madhya Pradesh, India | |||
| Qantas Biopharma Private Limited | ₹7.54 Lakh (FY 2024) | 36.0% | Hisar, Haryana, India | |||
| Yajas Pharmaceuticals Private Limited | ₹7.53 Lakh (FY 2024) | 161.0% | Palghar, Maharashtra, India |
To see the full peer comparison of Adreno Pharmaceuticals Private Limited, buy the company report.
Auditor
Adreno Pharmaceuticals Private Limited is audited by GUPTA SACHDEVA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA SACHDEVA & CO | FY 2022 | 006706N |
Shareholding
The shareholding of Adreno Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Adreno Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 03 Nov 2023 | 100845775 | Hdfc Bank Limited | ₹6.43 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Adreno Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Adreno Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Adreno Pharmaceuticals has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAOCA7338Q1ZU | Delhi | Active | 01 Jul 2017 |
| 19AAOCA7338Q1ZP | West Bengal | Active | 25 Jun 2021 |
To see the full GST registrations and return filing status of Adreno Pharmaceuticals Private Limited, buy the company report.
Recent activity
Adreno Pharmaceuticals Private Limited has 4 board changes on record since 2016: 2 appointments and 2 cessations. The latest: Kabita Roy ceased to be Additional Director on 30 Sep 2019.
Frequently asked questions
Adreno Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 08 September 2016 (10+ years old) and is registered under CIN U33100DL2016PTC305661.
Adreno Pharmaceuticals has 2 current directors:
- Prasenjit Nandi - Director
- Kabita Roy - Director
The latest financial statements of Adreno Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Adreno Pharmaceuticals is 07AAOCA7338Q1ZU, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 19AAOCA7338Q1ZP (West Bengal).
The CIN (Corporate Identification Number) of Adreno Pharmaceuticals is U33100DL2016PTC305661. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Adreno Pharmaceuticals was incorporated on 08 September 2016, making it 10+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Adreno Pharmaceuticals by revenue are Medopex Remedies Private Limited, Ulabs Private Limited, Sangfroid Medi Care Private Limited, Qantas Biopharma Private Limited, Yajas Pharmaceuticals Private Limited, all in the Healthcare industry (Healthcare Equipment Retail and Distribution, Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Kabita Roy ceased to be Additional Director on 30 Sep 2019. Kabita Roy was appointed as Director on 04 Jun 2019. Subroto Kumar Ghosh ceased to be Director on 04 Jun 2019. Adreno Pharmaceuticals has 4 board changes on record in total.
The registered office of Adreno Pharmaceuticals is at Unit No. G – 11 Ground Floor Vardhman Ac Market C.S.C Block – E Sector – 18 Rohini New De, Lhi, New Delhi, Delhi, India – 110089.
Adreno Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Adreno Pharmaceuticals has open charges of ₹6.43 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
